Heparin and Warfarin - Sydney South West Area Health Service
Heparin and Warfarin - Sydney South West Area Health Service
Heparin and Warfarin - Sydney South West Area Health Service
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Sydney</strong> <strong>South</strong> <strong>West</strong> <strong>Area</strong> <strong>Health</strong> <strong>Service</strong><br />
Guideline No: SSW_GL2007_010<br />
Date issued: November 2007<br />
ANTICOAGULATION: HEPARIN AND WARFARIN<br />
CONTENTS<br />
1. Intravenous Unfractionated <strong>Heparin</strong> Protocols…………………………………….............3<br />
1.1 <strong>Heparin</strong> Protocol for Acute Coronary Syndrome<br />
1.2 <strong>Heparin</strong> Protocol for Atrial Fibrillation, Venous <strong>and</strong> Arterial Thromembolic<br />
Disease, Prosthetic Heart Valves<br />
1.3 Notes on Intravenous <strong>Heparin</strong><br />
1.4 Safety Issues with Infusion Pumps<br />
1.5 Changing between Intravenous <strong>Heparin</strong> <strong>and</strong> Clexane<br />
2. Low Molecular Weight <strong>Heparin</strong> (Thromboembolism <strong>and</strong> Unstable Coronary<br />
Artery Syndromes)………………………………………………………………………….....5<br />
2.1 Products <strong>and</strong> Availability<br />
2.2 Before Starting Treatment<br />
2.3 Dose<br />
2.4 Administration<br />
2.5 Precautions<br />
2.6 Monitoring<br />
2.7 Charts for Estimating GFR<br />
3. Management of Bleeding on Intravenous St<strong>and</strong>ard <strong>and</strong> low Molecular Weight<br />
<strong>Heparin</strong>…………………………………..…………………………………………………….10<br />
3.1 Intravenous Unfractionated <strong>Heparin</strong><br />
3.2 Low Molecular Weight (LMW) <strong>Heparin</strong><br />
3.3 Precautions with Protamine<br />
4. Initiation of <strong>Warfarin</strong> Therapy………….……………………………………………………11<br />
4.1 Pre-Treatment<br />
4.2 Commencement of Therapy<br />
4.3 Initiation of warfarin Algorithm<br />
5. Rang of International Normalised Ratio (INR) Recommended for Specific<br />
Applications for <strong>Warfarin</strong> Therapy…….……………………………………………………13<br />
6. Duration of Anticoagulation…………….……………………………………………………13<br />
7. Managing High INR <strong>and</strong> Bleeding During <strong>Warfarin</strong> Therapy……………………………14<br />
7.1 Blood Products<br />
7.2 Vitamin K<br />
8. Patient Information on <strong>Warfarin</strong>…………………………………………………………….15<br />
9. Perioperative Management of Anticoagulent Therapy in Patients on <strong>Warfarin</strong>……….16<br />
9.1 Thrombotic Risk<br />
ATTACHMENT 1: Perioperative Management of Anticoagulent Therapy<br />
ATTACHMENT 2: Intravenous St<strong>and</strong>ard <strong>Heparin</strong> Protocols for 300 unit / mL Infusion<br />
Compliance with this guideline is recommended Page 2 of 24